BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36882604)

  • 1. Assessment of ultrasound features of placenta accreta spectrum in women at high risk: association with outcome and interobserver concordance.
    Bhide A; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):137-142. PubMed ID: 36882604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum.
    Jauniaux E; D'Antonio F; Bhide A; Prefumo F; Silver RM; Hussein AM; Shainker SA; Chantraine F; Alfirevic Z;
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):518-525. PubMed ID: 36609827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.
    Jauniaux E; Hussein AM; Thabet MM; Elbarmelgy RM; Elbarmelgy RA; Jurkovic D
    Am J Obstet Gynecol; 2023 Oct; 229(4):445.e1-445.e11. PubMed ID: 37187303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of preoperative ultrasound signs associated with bladder injury during complex Cesarean delivery: case-control study.
    Hussein AM; Thabet MM; Elbarmelgy RA; Elbarmelgy RM; Jauniaux E
    Ultrasound Obstet Gynecol; 2024 Jun; 63(6):781-788. PubMed ID: 38243910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
    Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface.
    Jauniaux E; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Burton GJ
    Am J Obstet Gynecol; 2022 Feb; 226(2):243.e1-243.e10. PubMed ID: 34461077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a prenatal sonographic scoring system and a clinical grading at delivery for Placenta Accreta Spectrum disorders.
    Pekar-Zlotin M; Maymon R; Eliassi Revivo P; Ezratty J; Melcer Y; Kugler N; Jauniaux E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8810-8816. PubMed ID: 34818979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.
    Skupski DW; Duzyj CM; Scholl J; Perez-Delboy A; Ruhstaller K; Plante LA; Hart LA; Palomares KTS; Ajemian B; Rosen T; Kinzler WL; Ananth C;
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):465-473. PubMed ID: 34725869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation sign: novel ultrasound sign for ruling out diagnosis of placenta accreta spectrum.
    Allwood RX; Self A; Collins SL
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):390-395. PubMed ID: 35837717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancy.
    Abinader RR; Macdisi N; El Moudden I; Abuhamad A
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):457-464. PubMed ID: 34837427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver agreement on standardized ultrasound and histopathologic signs for the prenatal diagnosis of placenta accreta spectrum disorders.
    Zosmer N; Jauniaux E; Bunce C; Panaiotova J; Shaikh H; Nicholaides KH
    Int J Gynaecol Obstet; 2018 Mar; 140(3):326-331. PubMed ID: 29143321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta.
    Jauniaux E; Hussein AM; Zosmer N; Elbarmelgy RM; Elbarmelgy RA; Shaikh H; Burton GJ
    Am J Obstet Gynecol; 2020 Apr; 222(4):379.e1-379.e11. PubMed ID: 31730756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 20. Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases.
    Aryananda RA; Duvekot JJ; Van Beekhuizen HJ; Cininta NI; Ariani G; Dachlan EG
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):93-102. PubMed ID: 37968904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.